Search Results for: bioblast

Israeli bio-techs merge

I reported previously (see here) on Jerusalem-based immunotherapy company Enlivex Therapeutics. Enlivex has merged with Tel Aviv-headquartered Bioblast (see here), which is developing treatments for rare genetic diseases. https://www.calcalistech.com/ctech/articles/0,7340,L-3759270,00.html

Posted in Israel's Medical Achievements | Leave a comment

Muscular dystrophy treatment success

Israel’s BioBlast announced promising interim results from its Phase II study of its Cabaletta treatment for oculopharyngeal muscular dystrophy (OPMD). Due to the success BioBlast seeks to fast track a Phase III study in 2016, leading to a 2017 launch … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Fast track for Muscular Dystrophy treatment

The US FDA has given fast track approval to Israel’s BioBlast for its Cabaletta treatment for two rare and currently untreatable conditions – oculopharyngeal muscular dystrophy (OPMD) and spinocerebellar ataxia type 3 (SCA3). http://www.israel21c.org/drug-for-rare-muscular-dystrophy-fast-tracked/

Posted in Israel's Medical Achievements | 2 Comments